We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$182B
AUM Growth
+$5.26B
Cap. Flow
-$3.52B
Cap. Flow %
-1.93%
Top 10 Hldgs %
11.63%
Holding
5,141
New
639
Increased
1,734
Reduced
1,574
Closed
583

Sector Composition

Rank Sector Weight
1 Technology 18.6%
2 Consumer Discretionary 9.12%
3 Healthcare 7.62%
4 Industrials 7.14%
5 Financials 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPWR.WS icon
4401
NET Power Inc Warrants
NPWR.WS
$26.2M
$7.52K ﹤0.01%
15,032
VEEAW
4402
Veea Inc Warrant
VEEAW
$7.21K ﹤0.01%
90,749
SHFSW icon
4403
SHF Holdings Warrants
SHFSW
$7.13K ﹤0.01%
188,000
KIDZW
4404
KIDZ AI Inc Warrants
KIDZW
$140K
$6.9K ﹤0.01%
575,000
OSRHW
4405
OSR Health Warrant
OSRHW
$256K
$6.74K ﹤0.01%
150,000
LOTWW
4406
Lotus Technology Inc Warrants
LOTWW
$6.48K ﹤0.01%
117,840
FUSEW
4407
Fusemachines Inc Warrants
FUSEW
$6.2K ﹤0.01%
+99,999
New +$14.4K
ABLVW icon
4408
Able View Global Warrant
ABLVW
$109K
$5.76K ﹤0.01%
200,000
RNWWW
4409
ReNew Energy Global PLC Warrant
RNWWW
$9.26K
$5.33K ﹤0.01%
591,955
ABPWW
4410
DELISTED
Abpro Holdings Warrant
ABPWW
$5.25K ﹤0.01%
375,000
KVACW
4411
DELISTED
Keen Vision Acquisition Corp Warrant
KVACW
$4.95K ﹤0.01%
97,000
SCAGW
4412
Scage Future Warrants
SCAGW
$374K
$4.47K ﹤0.01%
68,749
ZEOWW
4413
Zeo Energy Corp Warrants
ZEOWW
$103K
$4.45K ﹤0.01%
125,000
COCHW icon
4414
Envoy Medical Warrant
COCHW
$415K
$4.38K ﹤0.01%
113,431
ESLAW icon
4415
Estrella Immunopharma Warrant
ESLAW
$166K
$4.38K ﹤0.01%
87,500
PDYNW icon
4416
Palladyne AI Corp Warrants
PDYNW
$238K
$3.59K ﹤0.01%
58,622
APLMW icon
4417
Apollomics Inc Warrant
APLMW
$993K
$3.54K ﹤0.01%
318,530
PBMWW
4418
Psyence Biomedical Warrant
PBMWW
$392K
$3.45K ﹤0.01%
175,352
SPWRW
4419
SunPower Inc Warrants
SPWRW
$1.04M
$3.34K ﹤0.01%
12,382
ASBPW
4420
Aspire Biopharma Warrant
ASBPW
$314K
$3.3K ﹤0.01%
199,999
SMXWW
4421
SMX (Security Matters) Public Ltd Warrant
SMXWW
$728K
$3.01K ﹤0.01%
79,166
PRENW
4422
Prenetics Global Ltd Warrant
PRENW
$158K
$2.94K ﹤0.01%
104,515
LIMNW
4423
Liminatus Pharma Warrants
LIMNW
$349K
$2.92K ﹤0.01%
83,353
NIVFW
4424
NewGenIvf Group Warrants
NIVFW
$2.87K ﹤0.01%
168,750
BETRW icon
4425
Better Home & Finance Warrant
BETRW
$1.8M
$2.72K ﹤0.01%
27,202

Similar funds

David Shaw's Q4 2025 Portfolio in Review

As of Q4 2025, David Shaw held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
  • David Shaw added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
  • David Shaw's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
  • David Shaw fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
  • David Shaw's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
  • David Shaw opened 639 new positions and closed 583 in Q4 2025.
  • David Shaw's portfolio value rose 3% quarter-over-quarter to $182B.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.